Abstract | BACKGROUND: METHODS: Sprague-Dawley rats were subcutaneously injected with Iso to induce heart failure, which promoted renal fibrosis; rats with spironolactone treatment were given a gavage of spironolactone (30 or 60 mg/kg/d, for 21 days). Cardiac function and fibrosis indices were measured. Pathological alterations and expression of Type I and III collagen, α-smooth muscle actin, cluster of differentiation-31, and TGF-β were examined. RESULTS: In Iso-induced heart failure in rats, spironolactone significantly improved cardiac function and decreased myocardial fibrosis, reduced collagen fibrous proliferation in kidney, reduced expression of Type I and III collagen, increased the expression of cluster of differentiation-31, and decreased the expression of α-smooth muscle actin and TGF-β. CONCLUSION:
|
Authors | Hao Zhou, Dan Xi, Jichen Liu, Jinjin Zhao, Si Chen, Zhigang Guo |
Journal | Drug design, development and therapy
(Drug Des Devel Ther)
Vol. 10
Pg. 1581-8
( 2016)
ISSN: 1177-8881 [Electronic] New Zealand |
PMID | 27217725
(Publication Type: Journal Article)
|
Chemical References |
- Transforming Growth Factor beta
- Transforming Growth Factor beta1
- Spironolactone
|
Topics |
- Animals
- Epithelial-Mesenchymal Transition
(drug effects)
- Heart Failure
(drug therapy)
- Kidney Diseases
(pathology)
- Rats
- Spironolactone
(chemistry, pharmacology)
- Transforming Growth Factor beta
(chemistry, metabolism)
- Transforming Growth Factor beta1
(chemistry, metabolism)
|